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Abstract
Background: Highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS) has caused large
economic losses in swine industry in recent years. However, current antiviral strategy could not effectively prevent
and control this disease. In this research, five artificial microRNAs (amiRNAs) respectively targeted towards ORF5
(amirGP5-243, -370) and ORF6 (amirM-82, -217,-263) were designed and incorporated into a miRNA-based vector
that mimics the backbone of murine miR-155 and permits high expression of amiRNAs in a GFP fused form
mediated by RNA Pol II promoter CMV.
Results: It was found that amirGP5-370 could effectively inhibit H-PRRSV replication. The amirM-263-M-263, which
was a dual pre-amiRNA expression cassette where two amirM-263s were chained, showed stronger virus inhibitory
effects than single amirM-263. H-PRRSV replication was inhibited up to 120 hours in the MARC-145 cells which
were stably transduced by recombinant lentiviruses (Lenti-amirGP5-370, -amirM-263-M-263). Additionally, efficacious
dose of amirGP5-370 and amirM-263 expression did not trigger the innate interferon response.
Conclusions: Our study is the first attempt to suppress H-PRRSV replication in MARC-145 cells through vector-
based and lentiviral mediated amiRNAs targeting GP5 or M proteins coding sequences of PRRSV, which indicated
that artificial microRNAs and recombinant lentiviruses might be applied to be a new potent anti-PRRSV strategy.
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Background
Porcine reproductive and respiratory syndrome (PRRS) is
one of the most significant viral diseases in swine and it
threats global swine industries [1]. It has been reported
that approximately 560.32 million US dollars lost annually
only in the US [2]. The causative of PRRS is porcine repro-
ductive and respiratory syndrome virus (PRRSV), which is
an enveloped, single-stranded positive-sense RNA virus
and a member of the order Nidovirales, family Arteriviri-
dae [3]. The PRRSV genome, approximately 15 kb in
length, encodes nine partially overlapping open reading
frames (ORFs). Among them, ORF5 and ORF6 respec-
tively encodes two PRRSV major envelope structural pro-
teins: a glycosylated major envelope protein GP5 encoded
by ORF5 and an unglycosylated membrane M protein
encoded by ORF6 [4]. Both of these proteins are important
to PRRSV infection [5-9], for example, PRRSV M/GP5
complex acts as the ligand to interact macrophage-specific
lectin sialoadhesin which is critical for viral infection [10].
In recent years, highly pathogenic porcine reproductive
and respiratory syndrome (HP-PRRS) caused by highly
pathogenic porcine reproductive and respiratory syndrome
virus (H-PRRSV) is endemic in China and has resulted in
enormous economic losses in swine-producing areas of
the world [11,12]. However, current antiviral strategy
could not effectively prevent and control H-PRRSV.
Hence, it is imperative to develop a safe and effective anti-
viral strategy to combat H-PRRSV infection.
RNA interference (RNAi) is a conserved natural
mechanism by which homologous small interference
RNA (siRNA) duplexes induce potent and sequence-spe-
cific posttranscriptional inhibition of gene expression via
degradation of complementary messenger RNA (mRNA)
[13,14]. Since PRRSV is a RNA virus, its RNA genome is
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any medium, provided the original work is properly cited.not only the template for viral transcription but also for
viral genome replication. Antiviral RNAi might be more
potent to be applied to inhibit RNA viruses, such as
PRRSV [15,16]. On the other hand, due to PRRSV infec-
tion in pigs is time persistent [17], there is a need to use
stable antiviral RNAi therapy to durably protect pigs to
combat PRRSV infection. Lentiviral vectors allow expres-
sing exogenous DNA to induce stable and long-term
gene silence in dividing and non-dividing cells [18,19].
RNAi against viral infection based on lentiviral delivery
has been intensively investigated and evaluated for poten-
tial therapeutic applications in HIV-1, Hepatitis viruses
(Hepatitis B, HBV and Hepatitis C, HCV), Human papil-
loma virus, Coxsackie virus, Encephalitogenic flaviviruses,
Prion disease, etc (reviewed in [20]). Recently, artificial
microRNAs (amiRNAs) have been shown to be more
effective than conventional short hairpin RNA (shRNA)
as an antiviral strategy [20-25].
In this research, two recombinant plasmids expressing
amiRNAs, which are designed to be perfectly homolo-
gous to PRRSV GP5 and M proteins coding sequences
respectively, were found to be capable of inhibiting H-
PRRSV replication without inducing innate interferon
response. Additionally, it was found that H-PRRSV repli-
cation could be effectively inhibited in MARC-145 cells
up to 120 h at least by stably transduced with recombi-
nant lentiviruses expressing verified amiRNAs.
Results
AmiRNAs design and target sites selection using
luciferase assay
Artificial microRNAs (amiRNAs), which were designed
using online tools (Invitrogen), target PRRSV GP5 and
M proteins coding sequences, as shown in Figure 1 and
2A. Then recombinant plasmids expressing amiRNAs
were constructed and co-transfected with duel-luciferase
report plasmids psiCHECK2-GP5 or psiCHECK2-M into
293FT cells using lipofectamine 2000 (Invitrogen), as
shown in Figure 2B. In the luciferase assay, Renilla luci-
ferase signals were normalized to the firefly luciferase
signals in order to correct the differences of transfection
efficiencies. Relative luciferase expression in the pre-
sence of psiCHECK2 alone was set at 100%. We
observed that inhibitory effects of all the amiRNAs were
more than 70%. The relative renilla luminescence (RLU)
activities in amiRNAs transfected cells were significantly
lower than that in the cells transfected with psiCHECK2
alone (p < 0.05). Negative amiRNA transfected cells did
not show significantly reduction in RLU activity com-
pare to psiCHECK2 alone transfected cells (Figure 2C
and 2D). Moreover, expect for amir-82, the inhibitory of
amiRNAs were dose-dependent (Figure 2C and 2D).
Construction of plasmids and titering lentiviral stock
Six amiRNAs expressing plasmids (pcDNA™6.2-GW/
EmGFP-amirGP5-243; -amirGP5-370; -amirM-82;
-amirM-217; -amirM-263; -amirM-263-M-263), two luci-
ferase report plasmids psiCHECK2-GP5 and psiCHECK2-
M, and three recombinant lentiviral expression plasmids
(pLenti6/V5-GW/EmGFP-amirGP5-370; -amirM-263-M-
263; -negative amiRNA) were constructed. All the nucleo-
tides sequences inserted into vectors were confirmed by
sequencing. The titers of the three recombinant lentiviruses
were 3.35 × 10
6 TU/ml (Lenti-amirGP5-370), 3.33 × 10
6
TU/ml (Lenti-amirM-263-M-263), 1.81 × 10
6 TU/ml
(Lenti-negative amiRNA).
Inhibition of cytopathic effect (CPE) induced by H-PRRSV
in MARC-145
To determine whether amiRNAs could inhibit CPE
induced by H-PRRSV and protect MARC-145 cells,
MARC-145 cells were transfected with plasmids expres-
s i n ga m i R N A st h a tt a r g e tP R R S VG P 5a n dMp r o t e i n
coding sequence. In parallel, a nonspecific amiRNA that
does not target any known vertebrate genes was trans-
fected. Transfection efficiency was determined by GFP
fluorescence intensity of transfected cells on an inverted
fluorescence microscope. At six hours after transfection,
MARC-145 cells were infected with H-PRRSV. Sixty-
hour post-infection, we found that cells pre-transfected
with pcDNA™6.2-GW/EmGFP-amirGP5-370 or
pcDNA™6.2-GW/EmGFP-amirM-263-M-263 showed
less CPE compared to others. MARC-145 cells treated
with pcDNA™6.2-GW/EmGFP-neagtive-amiRNA
demonstrated the same typical PRRSV-induced CPE as
cells that infected with H-PRRSV alone (positive control),
which became reticulated and detached from the mono-
layer, as shown in Figure 3.
Figure 1 Genomic structure of PRRSV and target positions of artificial microRNAs (amiRNAs).
Xiao et al. Virology Journal 2011, 8:491
http://www.virologyj.com/content/8/1/491
Page 2 of 11AmiRNAs specifically silence PRRSV genes in H-PRRSV
infected MARC-145 cells
To determine whether the viral suppression was due to
specific viral gene expression inhibition, the cells were
infected with H-PRRSV at six hours post-transfected
with amiRNAs expressing plasmids. At sixty-hour post-
infection, the cells were harvested to detect H-PRRSV
GP5 or M protein coding genes and b-actin gene in
each experimental group by real-time PCR. b-actin gene
was served as an internal reference. AmirGP5-370
showed highest inhibition of expression of its target
gene (GP5 protein coding gene) in H-PRRSV infected
MARC-145 cells (p < 0.05) (Figure 4). AmirM-263-M-
263, which was a duel pre-amiRNA in one expression
cassette chained by two amirM-263s, was found to have
higher inhibitory effect than single amirM-263 (Figure 4
and Figure 5). It was also found that expression of H-
PRRSV GP5 and M protein coding genes were down
regulated in dose-dependent by amirGP5-370 and
amirM-263-M-263, respectively, compared to the
negative amiRNA treated and H-PRRSV infected alone
groups (Figure 5).
To investigate viral proteins expression, PRRSV were
detected by IFA and WB with PRRSV positive serum iso-
lated from SPF pigs. As shown in Figure 6A, compared
with infected alone group and negative amiRNA treated
group, amirGP5-370 and amirM-263-M-263 greatly
reduced frequency of fluorescence stained MARC-145
cells in IFA assay. It was observed that N protein amount
in amirGP5-370 or amirM-263-M-263 treated groups are
greatly reduced than infected alone and negative
amiRNA treated groups (Figure 6B). Moreover, the inhi-
bitory effect of amirM-263-M-263 was still dose depen-
dent(Figure 6B).
Interferon response is not triggered by efficacious
amiRNAs
Double stranded RNA (dsRNA) [26] may induce innate
immune response, and activation of the type I interferon
(IFN) pathway by small interfering RNA (siRNA) is a
Figure 2 Designed amiRNAs and target sites selection using luciferase assay. Five amiRNAs were designed via online tools of Invitrogen
Company (A). Transfection efficiency assay via GFP monitoring after co-transfected with plasmids expressing amiRNAs that fused to GFP coding
gene and psiCHECK2-GP5 or -M. Images were taken with an inverted fluorescence microscope in bright (left) or fluorescence (right) light of the
same field. Magnification, 40× (upper) or 100 × (bottom) (B). Inhibition of Renilla luciferase expression by amiRNAs that targeting PRRSV GP5 or
M protein coding sequences were measured by duel luciferase assay at 48 hours post-cotransfection. The Renilla luciferase data has been
normalized to firefly luciferase data. Normalized Renilla luciferase expression in the psiCHECK2 only transfection was set at 100%. Data are mean
± SD, n = 3~4, *p < 0.05 vs. psiCHECK alone transfected cells group (C, D).
Xiao et al. Virology Journal 2011, 8:491
http://www.virologyj.com/content/8/1/491
Page 3 of 11Figure 3 CPE analysis of H-PRRSV on MARC-145 cells transfected with pcDNATM6.2-GW/EmGFP -amirGP5-370, -amirM-263-M-263 or
-negative amiRNA. Cells were challenged with H-PRRSV at 0.01 MOI and incubated for 60 hours, Magnification 100×.
Figure 4 Inhibition on H-PRRSV GP5 and M expression by
amiRNAs were observed by qPCR. The mRNA of b-actin was
served as an internal reference. GP5 and M protein coding genes
expression normalized to b-actin gene in negative amiRNA
transfected cells group was set at 100%. Data are mean ± SD, n = 3,
*p < 0.05 vs. negative amiRNAs alone transfected cells group.
Figure 5 Dose-dependent inhibition on specific H-PRRSV gene
expression by amirGP5-370 and amirM-263-M-263 was
observed by qPCR. The mRNA of b-actin was served as an internal
reference. GP5 and M protein coding genes expression normalized
to b-actin gene in negative amiRNA transfected cells group was set
at 100%. Data are mean ± SD, n = 3~4, *p < 0.05 vs. negative
amiRNAs alone transfected cells group.
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Page 4 of 11Figure 6 AmiRNAs expression plasmids inhibit specific H-PRRSV protein expression in MARC-145 cells. Cells seeded in 96-well (for
indirect fluorescence assay, IFA) or 12-well (for Western blotting, WB) plates were transfected amiRNAs expression plasmids, and infected with H-
PRRSV at 0.01 MOI at six-hour post-infection. At sixty hours after infection, PRRSV was detected by IFA and WB with PRRSV positive serum
isolated from SPF pigs. Pictures were taken with an inverted fluorescence microscope. Magnification, 100×(A). Whole cell extracts of experimental
groups were prepared for WB and b-actin protein was served as an internal reference (B). The data here was one represent of three experiments.
Xiao et al. Virology Journal 2011, 8:491
http://www.virologyj.com/content/8/1/491
Page 5 of 11major contributor to the off-target effects of RNA inter-
ference in mammalian cells [27]. To detect possible
induction of innate immune response by amiRNAs, RT-
PCR analysis of IFN-b and 2,5-oligoadenylate synthetase
(OAS) were carried out in the experiment groups that
were transfected efficacious dose amiRNAs expressing
plasmids. It was observed that amplifications of IFN-b
and OAS were absence in the ethidium bromide stained
agarose gels (Figure 7). Meanwhile cells treated with poly
I:C was set as positive control, in which IFN-b and OAS
genes can be detected (Figure 7).
Duration of inhibitory effects on H-PRRSV in MARC-145
cells that stably transduced with Lenti-amiRNAs
To analyze the persistent inhibition of H-PRRSV by
amiRNAs, stably transduced MARC-145 cells with Lenti-
amirGP5-370, Lenti-amirM-263-M-263 or Lenti-negative
amiRNA were selected by using 8 μg/ml Blasticidin. Blas-
ticidin-resistant colonies were picked and expanded.
MARC-145 cells that stably express amirGP5-370,
amirM-263-M-263 or negative amiRNA were infected
with H-PRRSV at 5.0MOI. Cell cultures were harvested
at 72, 96 and 120 h post-infection and then were assayed
for CCID50. We found that H-PRRSV titers were at least
approximately 1000-fold lower in MARC-145 cells
expressing amirGP5-370 or amirM-263-M-263 compared
to those infected with H-PRRSV alone or expressing
negative amiRNA (Figure 8).
Discussion
Vaccination is the principal means used to control and
treat PRRSV infection. An array of PRRS vaccines have
been developed, but these all could not provide sustain-
able disease control because they suffer both from the
immune evasion strategies of the virus and the antigenic
heterogeneity of field strains [28]. Hence, it is imperative
to develop a safe and effective antiviral strategy to com-
bat PRRSV infection. RNAi is a process of gene silencing
which can be induced by intracellular expression of short
hairpin RNA (shRNA) or artificial microRNA (amiRNA)
delived by vectors or viruses. Previous researches have
been demonstrated that PRRSV replication could be
inhibited by RNAi induced by recombinant plasmids or
adenoviruses expressing shRNAs [29-33]. Chen et al.
(2006) demonstrated that adenovirus-mediated FMDV-
specific shRNA could significantly reduce the susceptibil-
ity of swine to FMDV infection [34]. Carmona et al.
(2006) demonstrated that anti-HBx shRNA could effec-
tively inhibited HBV replication [35].
However, shRNAs are not the optimal substrate for
RNAi process in that shRNAs will not be processed by
Drosha that could create cleavage sites for further cleave
by Dicer which is critical for efficient RNAi effect [36].
Therefore, it is required many candidate shRNA sequences
to identify the effective ones. On the other hand, shRNA
expressing vectors always use Polymerase III promoters,
which not only limits tissue-specific expression of shRNA
but also has shown to have higher possibilities to induce
cellular toxicities due to over expression of shRNA driven
by Polymerase III promoters might interfere with endogen-
ous microRNA biogenesis [37].
Recently, pre-artificial microRNAs (pre-amiRNA) dri-
ven by Polymerase II promoters that via naturally existing
endogenous microRNA pathway to become mature
amiRNA have shown to be more potent antiviral RNAi
inducers but with less dangerous of toxicities compared
to conventional shRNAs [20-25]. RNA polymerase II is
tightly regulated and it can drive tissue-specific amiRNA
Figure 7 Artificial microRNAs do not trigger IFN activation.
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Page 6 of 11Figure 8 Duration of inhibitory effects on H-PRRSV in MARC-145 cells that stably transduced with Lenti-amiRNAs.S t a b l yt r a n s d u c e d
MARC-145 cells were generated by recombinant lentiviruses via Blasticidin (8 μg/ml) selection. Images were taken with an inverted fluorescence
microscope in bright (upper) or fluorescence (bottom) light of the same field, Magnification 200× (A). MARC-145 cells that were stably
transduced with amirGP5-370, amirM-263-M-263 and negative amiRNA were infected with H-PRRSV at 5.0MOI. At 72, 96 and 120 hours post-
infection, cell cultures were harvested, respectively, and virus titers were assayed by CCID50 (B).
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saturation caused by overexpression of exogenous
shRNAs will be avoided by utilizing RNA polymerase II
driven amiRNA expression constructs [38-41]. However,
this has not been applied in the anti-PRRSV RNAi
strategy.
In this research, five amiRNAs (amirGP5-243, amirGP5-
370, amirM-82, amirM-217 and amirM-263) targeting
PRRSV GP5 or M proteins coding sequences were
designed via online tool. Then recombinant plasmids
expressing theses amiRNAs were constructed. In the duel
luciferase signal assay experiment, we observed that all
amiRNAs could inhibit Renilla luciferase signal at least
70% via cleavage their target sequences. Except for
amirM-82, inhibitory effects of all the other amiRNAs
were found to be in dose dependent (Figure 2C and 2D).
Our results indicated that amiRNAs-mediated RNAi
might be a potent method to induce gene silence.
To investigate whether amiRNAs could inhibit accumu-
lation of viral mRNAs or proteins of target genes, we car-
ried out CPE analysis, real-time PCR, IFA and Western
blotting assays. Among five amiRNAs tested in this study,
amirGP5-370 showed the highest inhibitory effect on H-
PRRSV replication and ORF5 gene expression in MARC-
145 cells infected with H-PRRSV (Figure 4). Other four
amiRNAs that were verified to be able to cleave target
gene in duel luciferase assays failed to effectively knock
down target viral genes in MARC-145 cells with H-
PRRSV infection. It may be because of limited transfection
efficiency and rapid replication of H-PRRSV. Efficiency of
transfection of plasmids into MARC-145 cells using Lipo-
fectamine 2000 in this study, which are measured by GFP
fluorescence intensity, is approximately more than 50%
(data not shown). Although this transfection efficiency is
slightly higher than previous study using MARC-145 cells
[30], it is still low and will underestimate the inhibition
effects due to viral replication in those MARC-145 cells
that failed to be transfected with amiRNAs. This case
became more obvious when cells infected with H-PRRSV
that will induce highly pathogenic lesions in cells. To com-
bat rapid replication of H-PRRSV, increased inhibitory
effects on target sequence are needed.
Chaining amiRNAs in one expression construct is per-
mitted for the plasmids we used in this research. It also
has been shown that increased gene knock-down effects
could be induced by repeating same amiRNA in one
expression construct. Among the other four amiRNAs,
which showed less effective inhibition on H-PRRSV repli-
cation, amirM-263 showed greatest inhibitory effects. In
this case, we chained two amirM-263s to construct a duel
pre-amiRNAs construct amirM-263-M-263. It was
observed that amirM-263-M-263 showed much higher
inhibitory effects on viral gene transcription compared to
amirM-263, and could inhibit H-PRRSV replication in
MARC-145 cells (Figure 5 and 6).
Plasmids or adenoviruses delivery strategy is limited by
its transient nature, as a result, RNAi effects were reduced
over time post-infected with PRRSV and PRRSV could
replicate afterwards. Also, PRRSV might develop certain
mechanism to escape RNAi effect [32], but it is difficult to
investigate possible virus escape in the condition of transi-
ent antiviral RNAi. Moreover, it has been shown that
PRRSV infection can persist in pigs after preliminary infec-
tion [17]. Taken together, antiviral RNAi against PRRSV
infection should be a relatively stable therapy that can dur-
ably protect pigs. Lentiviral vector is a powerful DNA
delivery tool that allows expressing exogenous DNA to
induce stable and long-term gene silence in dividing and
non-dividing cells [18,19]. To date, lentiviral mediated
RNAi have been intensively investigated for combat viral
infection (reviewed in [20]), but has not been reported to
be used as an anti-PRRSV strategy. In this research, one of
our aims is to investigate whether lentiviral mediated anti-
viral RNAi could persistently inhibit H-PRRSV replication
in MARC-145 cells. Three recombinant lentiviruses
expressing amirGP5-370, amirM-263-M-263 and negative
amiRNA, respectively, were produced in 293FT cells. The
results showed that H-PRRSV replication would be sup-
pressed in MARC-145 cells stably expressed amirGP5-370
or amirM-263-M-263 up to 120 hours post infection
(Figure 8).
Small interfering RNA (siRNA) may induce type I
interferon (IFN-I) activation, which will result in off-tar-
get effects of RNAi in mammalian cells [27]. However,
in our research, efficacious dose of amirGP5 and
amirM-263-M-263 will not trigger interferon response
(Figure 7).
Conclusions
We designed five artificial amiRNAs respectively targeting
PRRSV GP5 (amirGP5-243, -370) or M (amirM-82, -217,-
263) proteins coding sequences and constructed recombi-
nant plasmids expressing theses amiRNA. The results
showed that amirGP5-370 and amirM-263-M-263 could
effectively suppress H-PRRSV replication without inducing
innate interferon response. And H-PRRSV replication
could be effectively inhibited in MARC-145 cells up to
120 h at least by stably transduced with recombinant lenti-
viruses expressing verified amiRNAs. To our knowledge,
the study presented here is the first attempt to suppress
H-PRRSV replication in MARC-145 cells through vector-
based and lentiviral mediated amiRNAs targeting GP5 or
M proteins coding sequences of PRRSV. The study indi-
c a t e dt h a ta r t i f i c i a lm i c r o R N A sa n dr e c o m b i n a n tl e n t i -
viruses might be applied to be a new potent anti-PRRSV
strategy.
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Design of amiRNAs and construction of plasmids
expressing amiRNAs
Five precursor miRNAs (pre-miRNA) sequences respec-
tively targeting on PRRSV GP5 and M protein coding
genes were designed through an internet application sys-
tem (Invitrogen). Double-stranded oligonucleotide encod-
ing pre-miRNA sequence were annealed and inserted into
pcDNA™6.2-GW/EmGFP-miR expression vector (Invi-
trogen) containing cytomegalovirus (CMV) promoter and
herpes simplex virus thymidine kinase polyadenylation sig-
nal. All recombinant plasmids have been sequenced to
confirm the sequences inserted.
Cell cultures, transfection and virus infection
African green monkey kidney cell line MARC-145 were
applied to grow PRRSV and to determine virus titers.
Human embryo kidney cells (293FT) were applied to pro-
duce lentivirus. MARC-145 cells and 293FT cells were
both cultured in Dulbecco modified Eagle medium
(DMEM) supplemented with 10% Fetal Bovine Serum
(FBS), 2 mM L-glutamine, 0.1 mM MEM Non-Essential
Amino Acids, 1% penicillin/streptomycin, and 1 mM
MEM Sodium Pyruvate. Cells were typsinized and seeded
in 96-well, 12-well or 6-well plate nearly 24 hours before
tansfection. For transfection, lipofectamine 2000 (Invitro-
gen) was used according to manufacturer’s instruction. Six
hours post-transfection, MARC-145 cells were infected
with Highly pathogenic PRRSV GD isolate (kindly pro-
vided by Dr. Guihong Zhang in South China Agricultural
University, China) at a multiplicity of infection of 0.01 as
described in previous study [30].
Dual luciferase reporter assays
Luciferase reporter assays were performed using the psi-
CHECK2-GP5 and psiCHECK2-M. 293FT cells were
grown to approximately 80% confluence in 24-well plates
and cotransfected with psiCHECK2-GP5, psiCHECK2-M
or psiCHECK2 empty vector plus 0.2 μg, 0.5 μgo r0 . 8μg
pcDNA™6.2-GW/EmGFP-miR. Cells were incubated with
transfection reagent lipofectamine 2000/DNA complex for
6 hours and then refreshed with fresh DMEM containing
1% FBS for 48 hours. Firefly and Renilla luciferase activ-
ities were evaluated using the Dual-Luciferase Reporter
Assay system (Promega), and Renilla luciferase activity
was normalized to firefly luciferase activity.
Virus titration
MARC-145 cells were typsinized and seeded in 96-well
plate 24 hours before virus infection. Virus supernatants
w e r e1 0 - f o l ds e r i a l l yd i l u t e da n da d d e d1 0 0μlt oe a c h
well in eight repeated. Six days after infection, the 50%
cell culture infection dose (CCID50) was calculated by the
Reed-Muench method.
Analysis of PRRSV GP5 and M protein coding genes by
real-time PCR
T o t a lR N Aw a si s o l a t e df r o mM A R C - 1 4 5c e l l sa t6 0h
after H-PRRSV infection as described above using RNA-
preppure total cell RNA isolation kit (Tiangen, Beijing,
China). Genomic DNA was removed using DNase I
(NEB). 2 μg RNA was reverse-transcribed into first strand
cDNA with M-MLV transcriptase (Promega) and oligo d
(T)18 primers (TaKaRa). 1 μl cDNA was submitted to real-
time PCR analysis using specific primers for b-actin,
PRRSV GP5 and M protein coding genes. b-actin-
F:5’TGACTGACTACCTCATGAAGATCC3’;b-actin-
R:5’TCTCCTTAATGTCACGCACGATT3’ [30], GP5-
F:5’ACTCACCACCAGCCATTTC3’;GP5-R: 5’ CAGTTC
TTCGCAAGCCTAA 3’,M - F :5 ’ CACCTCCAGATGCC
GTTTG 3’;M - R :5 ’ ATGCGTGGTTATCATTTGCC 3’,
and SYBR
® Premix Ex Taq™ (TaKaRa). Real-time PCR
was performed in a LightCycler
® 480 Real-Time PCR Sys-
tem and analyzed with LightCycler
® 480software (Roche).
Amplification was carried out in a 10 μl reaction mixture
containing 5 μlS Y B R
® Premix Ex Taq™ (TaKaRa) 2×, 0.2
μM concentration of each primer, 1 μl cDNA. The reac-
tion procedure was 95°C 10s, followed by 40 cycles at
95°C for 5s and 60°C for 40s. b-actin gene was served as
an internal reference. To confirm specific amplification,
melting curve analysis was performed.
Indirect immunofluorescence
MARC-145 cells seeded in 96-well plate were trans-
fected with pcDNA™6.2-GW/EmGFP-amiR-GP5-370,
pcDNA™6.2-GW/EmGFP-amiR-M-263-M-263 or
pcDNA™6.2-GW/EmGFP-amiR-negative, and then
were infected with H-PRRSV. At 60 hours after virus
infection, MARC-145 cells were fixed with pre-cooled
methanol for 20 minutes on ice. Following three washes
by phosphate-buffer saline (PBS, pH7.4), the fixed
MAR-145 cells were incubated with PRRSV positive
serum for 2 hours at 37°C. Unbound antibodies were
washed three times with TBST. Then, FITC labeled goat
anti-pig IgG antibody (KPL) was added and incubated
for 1 hour at 37°C. After 3 washes by TBST, fluores-
cence was analyzed using a fluorescence microscopy
(Nikon).
Western blotting analysis
Western blotting was processed as described previously
[42]. The PVDF membrane was probed with a 1:100 dilu-
tion of PRRSV positive serum. To normalize protein load-
ing, the PVDF membrane was simultaneously incubated
with mouse b-actin monoclonal antibody (BioVision, CA,
USA) at a dilution of 1: 4,000. The horseradish peroxi-
dase-conjugated goat anti-pig IgG at a dilution of 1:1,000
and horseradish peroxidase-conjugated goat anti-mouse
IgG at a dilution of 1:5,000 was used as secondary
Xiao et al. Virology Journal 2011, 8:491
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signal west pico chemiluminescence substrate (Pierce, IL,
USA) and Image Quant RT ECL detector (GE).
RT-PCR for interferon assay
293FT cells were respectively transfected with 1 μg
amiRNA construct in 24-well plate (pcDNA™6.2-GW/
EmGFP-amiR-GP5-370 or pcDNA™6.2-GW/EmGFP-
amiR-M-263-M-263) using Lipofectamine 2000 (Invitro-
gen). The 2 μg poly I:C (Sigma) that was transfected into
293FT cells in 24-well plate served as a positive control for
innate response induction as described previously [25] and
native 293FT cells served as a negative control. Total RNA
was isolated from 293FT cells 24 h post-treated using
RNApreppure total cell RNA isolation kit (Tiangen, Beij-
ing, China). Genomic DNA was removed using DNase I
(NEB). RNA (2 μg) was reverse-transcribed into first
strand cDNA with M-MLV transcriptase (Promega) and
random hexamer primers (TaKaRa).
PCR amplification was performed on 1 μlR Tp r o d u c t
with interferon-b(IFN-b), 2’,5’-oligoadenylate synthetase
(OAS) and b-actin(endogenous control) specific primers.
IFN-b-F: 5’ GATTCATCTAGCACTGGCTGG 3’; IFN-b-
R: 5’ CTTCAGGTAATGCAGAATCC 3’(186 bp) [43],
OAS-F: 5’ AGTGCATCTTGGGGGAAAG 3’;O A S - R :5 ’
CATTACCCTCCCATCAGGTGC 3’ (302 bp) and b-
actin-F: 5’ GACTACCTCATGAAGATCCTCAC 3’; b-
actin-R: 5’ ATTGCCAATGGTGATGACCTG 3’ (197 bp)
[43].
Production of recombinant adenoviruses
The pDONR™ 211 vector was used as intermediate to
transfer the pre-amiRNA expression cassette constructed
before into the lentiviral expression plasmid (pLenti6/
V5-DEST) using Gateway technology (Invitrogen) to gen-
erate pLenti6/V5-GW/EmGFP-miR. The pLenti6/V5-
GW/EmGFP-miR then was co-transfected with packa-
ging vectors (Invitrogen) into 293FT cells using lipofecta-
mine 2000 (Invitrogen). The cell supernatants were
collected at 72 h post-transfection and used as a virus
stock. All lentiviruses expressed enhanced green fluores-
cence protein (GFP), allowing for titering and measuring
their infection efficiency in transfected cells. The viral
titers were determined by counting GFP-positive cells
after transduced in the presence of polybrene (6 μg).
Statistics
Statistical significance was determined by student’s t-test.
A P-value<0.05 was considered statistical significant. N
values represent the number independent experiments.
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